Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development (Q38220806)

31 August 2017

Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development (English)

1 reference

31 August 2017

1 reference

1

Deborah W Knapp

1 reference

31 August 2017

José A Ramos-Vara

2

1 reference

31 August 2017

George E Moore

3

1 reference

31 August 2017

Deepika Dhawan

4

1 reference

31 August 2017

Patty L Bonney

5

1 reference

31 August 2017

Kirsten E Young

6

1 reference

31 August 2017

1 January 2014

1 reference

31 August 2017

19

1 reference

based on heuristic

inferred from page(s)

published in

ILAR Journal

1 reference

31 August 2017

55

1 reference

31 August 2017

100-118

1 reference

31 August 2017

1

1 reference

Occupational pesticide exposures and cancer risk: a review.

31 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Pet dogs as sentinels for environmental contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Alterations of DNA methylome in human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cause-specific mortality of Dutch chlorophenoxy herbicide manufacturing workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

A population study of neutering status as a risk factor for canine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Epidemiology and risk factors of urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Prevalence of telomerase activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The origins of urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Histologic grading of urothelial carcinoma: a reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

DNMT1: an emerging target in the treatment of invasive urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Targeting folate receptors to treat invasive urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Diagnosis and classification of flat, papillary, and invasive urothelial carcinoma: the WHO/ISUP consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Gene polymorphisms in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Mesothelioma in pet dogs associated with exposure of their owners to asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial-an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Chemotherapy in advanced bladder cancer: current status and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Epidemiologic studies of risk factors for cancer in pet dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Current treatment of metastatic bladder cancer and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The role of the androgen receptor in the development and progression of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Low-dose metronomic chemotherapy: a systematic literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Chemotherapy of advanced transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Promotion of bladder cancer development and progression by androgen receptor signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Epidemiology of urinary bladder cancer: from tumor development to patient's death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

21 January 2018

Metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Man's best friend becomes biology's best in show: genome analyses in the domestic dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The present and future burden of urinary bladder cancer in the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cutaneous metastasis of transitional cell carcinoma in 12 dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Urethral carcinoma and hyperplasia in male and female B6C3F1 mice treated with 3,3',4,4'-tetrachloroazobenzene (TCAB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

UTIs in small animal patients: part 2: diagnosis, treatment, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Diagnosis and management of urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

The role of aspirin in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Neutering dogs: effects on joint disorders and cancers in golden retrievers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Hormonal and sex impact on the epidemiology of canine lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Telomere length and risk of incident cancer and cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Expression and function role of DNA methyltransferase 1 in human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Uroplakins in urothelial biology, function, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Cancer incidence in Korean Vietnam veterans during 1992-2003: the Korean veterans health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILU018

21 January 2018

Identifiers

DOI

10.1093/ILAR/ILU018

1 reference

31 August 2017

1 reference